It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
Author
Fong, Youyi 1 ; Huang, Yunda 2
; Benkeser, David 3
; Carpp, Lindsay N. 4
; Áñez, Germán 5
; Woo, Wayne 5 ; McGarry, Alice 5 ; Dunkle, Lisa M. 5 ; Cho, Iksung 5 ; Houchens, Christopher R. 6 ; Martins, Karen 6 ; Jayashankar, Lakshmi 6 ; Castellino, Flora 6 ; Petropoulos, Christos J. 7
; Leith, Andrew 8 ; Haugaard, Deanne 8 ; Webb, Bill 8 ; Lu, Yiwen 4 ; Yu, Chenchen 4 ; Borate, Bhavesh 4 ; van der Laan, Lars W. P. 9 ; Hejazi, Nima S. 10
; Randhawa, April K. 4
; Andrasik, Michele P. 4 ; Kublin, James G. 4 ; Hutter, Julia 11 ; Keshtkar-Jahromi, Maryam 11
; Beresnev, Tatiana H. 11 ; Corey, Lawrence 12
; Neuzil, Kathleen M. 13
; Follmann, Dean 14
; Ake, Julie A. 15 ; Gay, Cynthia L. 16
; Kotloff, Karen L. 13 ; Koup, Richard A. 17 ; Donis, Ruben O. 6 ; Gilbert, Peter B. 18
1 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622)
2 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Global Health, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
3 Emory University, Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
4 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622)
5 Novavax, Inc., Gaithersburg, USA (GRID:grid.436677.7) (ISNI:0000 0004 0410 5272)
6 Biomedical Advanced Research and Development Authority, Washington, USA (GRID:grid.476870.a)
7 LabCorp-Monogram Biosciences, South San Francisco, USA (GRID:grid.419316.8) (ISNI:0000 0004 0550 1859)
8 Nexelis, Seattle, USA (GRID:grid.419316.8)
9 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Statistics, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
10 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Harvard University, Department of Biostatistics, T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
11 National Institute of Allergy and Infectious Diseases, NIH, Division of Microbiology and Infectious Diseases, Rockville, USA (GRID:grid.419681.3) (ISNI:0000 0001 2164 9667)
12 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Laboratory Medicine and Pathology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
13 University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, USA (GRID:grid.411024.2) (ISNI:0000 0001 2175 4264)
14 National Institutes of Health, Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
15 Walter Reed Army Institute of Research, U.S. Military HIV Research Program, Silver Spring, USA (GRID:grid.507680.c) (ISNI:0000 0001 2230 3166)
16 University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
17 National Institutes of Health, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
18 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Biostatistics, School of Public Health, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)













1 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622)
2 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Global Health, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
3 Emory University, Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
4 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622)
5 Novavax, Inc., Gaithersburg, USA (GRID:grid.436677.7) (ISNI:0000 0004 0410 5272)
6 Biomedical Advanced Research and Development Authority, Washington, USA (GRID:grid.476870.a)
7 LabCorp-Monogram Biosciences, South San Francisco, USA (GRID:grid.419316.8) (ISNI:0000 0004 0550 1859)
8 Nexelis, Seattle, USA (GRID:grid.419316.8)
9 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Statistics, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
10 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Harvard University, Department of Biostatistics, T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
11 National Institute of Allergy and Infectious Diseases, NIH, Division of Microbiology and Infectious Diseases, Rockville, USA (GRID:grid.419681.3) (ISNI:0000 0001 2164 9667)
12 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Laboratory Medicine and Pathology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
13 University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, USA (GRID:grid.411024.2) (ISNI:0000 0001 2175 4264)
14 National Institutes of Health, Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
15 Walter Reed Army Institute of Research, U.S. Military HIV Research Program, Silver Spring, USA (GRID:grid.507680.c) (ISNI:0000 0001 2230 3166)
16 University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
17 National Institutes of Health, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
18 Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Biostatistics, School of Public Health, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
Pages
1581
Publication year
2023
Publication date
2023
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2789592399
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.